Washington [US], September 5 (ANI): Clinical researchers at the Washington University School of Medicine in St. Louis recently developed a new method to treat rheumatoid arthritis by genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.
\
\
